A report from the 46th Annual Meeting of the American Society of Clinical Oncology (June 4-8, 2010 - Chicago, Illinois, USA).
A report from the 46th Annual Meeting of the American Society of Clinical Oncology (June 4-8, 2010 - Chicago, Illinois, USA).
复制标题
DOI：
10.1358/dot.2010.46.9.1544004
复制
发表时间：
2010-09
期刊：
影响因子：
1.8
通讯作者：
X. Rabasseda;M. Gómez‐Zaera
中科院分区：
文献类型：
--
作者：
X. Rabasseda;M. Gómez‐Zaera
大型抗癌设备可用于治疗患有实体和血液恶性肿瘤的患者，但目前可用的癌症疗法在治愈疾病方面具有许多限制。因此，争取新的治疗方法是至关重要的，因为获得新疗法的第一手资料，因为它们变得可用。美国临床肿瘤学会（ASCO）年会通过传播新治疗方法和新干预目标的知识来帮助实现这一目标。为了补充ASCO的努力，并为我们的用户和读者的利益，本报告将提供今年会议的一瞥，特别关注目前可用的治疗和正在开发的研究药物，其抗癌活性在芝加哥会议期间报告。
A large anticancer armamentarium is available for treating patients with solid and hematological malignancies, but currently available therapies for cancer have many limitations in terms of curing the disease. Fighting for new therapies is thus essential, as is getting first-hand information on new therapies as they become available. The annual meeting of the American Society of Clinical Oncology (ASCO) helps serve that purpose by spreading knowledge on new treatments and new targets for intervention. To supplement ASCO's efforts and for the benefit of our users and readers, this report will offer a glimpse of what this year's meeting was like, giving special attention to currently available therapies and investigational drugs in development, the anticancer activity of which was reported during the meeting in Chicago.